5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dienoic acid delta-lactone,
withaferin A,
Withaferin A,
5119-48-2,
Withaferine A,
UNII-L6DO3QW4K5,
NSC 273757,
WITHAFERIN DERIV JPR, IOWA U. COMPOUND,
BRN 1335150,
L6DO3QW4K5,
Ashwagandha,
CHEBI:69120,
NSC-101088,
NSC101088,
4beta,27-dihydroxy-1-oxo-5beta,6beta-epoxywitha-2,24-dienolide,
5,6-Epoxy-4,27-dihydroxy-1-oxowitha-2,24-dienolide,
(4beta,5beta,6beta,22R)-4,27-dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione,
(4beta,5beta,6beta,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic acid, delta-lactone,
5-beta-Ergosta-2,24-dien-26-oic acid, 5,6-beta-epoxy-4-beta,22,27-trihydroxy-1-oxo-, delta-lactone, (20S,22R)-,
Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, gamma-lactone, (4bta,5beta,6beta,22R)-,
Withaferine,
5.beta.-Ergosta-2, 5,6.beta.-epoxy-4.beta.,22,27-trihydroxy-1-oxo-, .delta.-lactone, (20S,22R)-,
C28H38O6,
Ergosta-2, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,22R)-,
AC1L6DJ0,
5-19-06-00604 (Beilstein Handbook Reference),
MLS006010687,
SCHEMBL157208,
CHEMBL517080,
Withaferin A, analytical standard,
Withaferin A, >=95% (HPLC),
HY-N2065,
ZINC8234189,
MFCD10687098,
NSC273757,
5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dienoic acid delta-lactone,
NSC 101088,
NSC-273757,
NCGC00180796-02,
(4 beta,5 beta,6 beta,22R)-5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta- 2,24-dien-26-oic acid, delta-lactone,
LS-64535,
NCI60_000031,
SMR004701668,
B7199,
CS-0018562,
C08841,
A1-06845,
BRD-K88378636-001-01-0,
WLN: T3 F5 E666 1A R AXO OV PU CH&TTTTJ J1 N1 RQ IY1&- FT6OV CUTJ C1Q D1,
(20S,22R)-5,6|A-Epoxy-4|A,22,27-trihydroxy-1-oxo-5|A-ergosta-2,24-dien-26-oic Acid |A-Lactone,
(4|A,5|A,6|A,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic Acid |A-Lactone,
4|A,5|A,6|A,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid |A-lactone,
5beta-Ergosta-2,24-dien-26-oic acid, 5,6beta-epoxy-4beta,22,27-trihydroxy-1-oxo-, delta-lactone, (20S,22R)-,
5beta-Ergosta-2,24-dien-26-oic acid, 5,6beta-epoxy-4beta,22,27-trihydroxy-1-oxo-, delta-lactone, (20S,22R)- (8CI),
NCGC00180796-02_C28H38O6_(4beta,5beta,6beta,22R)-4,27-Dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione,
WITHAFERINA,
D0V3PN,
Withaferin A, 99% - 1MG 1mg,
AR-1G1030,
CID265237,
C28-H38-O6,
CS-O-14315,
C009684,
C030693,
HSF-1 inhibitor (melanoma), University of Kansas,
4b,27-dihydroxy-1-oxo-5b,6b-epoxywitha-2,24-dienolide,
Heat shock factor 1 inhibitor (melanoma), University of Kansas,
(4-beta,5-beta,6-beta,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic acid delta-lactone,
5.beta.-Ergosta-2,24-dien-26-oic acid, 5,6.beta.-epoxy-4.beta.,22,27-trihydroxy-1-oxo-, .delta.-lactone, (20S,22R)-,
51572-98-6,
Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,22R)-,